bims-ovagas Biomed News
on Ovarian aging and cGAS
Issue of 2026–08–02
five papers selected by
Haiyuan Mu, University of California Berkeley



  1. bioRxiv. 2026 Jul 23. pii: 2026.07.22.738304. [Epub ahead of print]
      Cumulus cells have well-established roles early in ovulation but the key molecules that drive their behavior in later stages, leading to follicle rupture, remain underexplored. Here, we observed that inhibition of proprotein convertases (PCSKs) via a pan-inhibitor (PCI) impaired follicular rupture and disrupted the cumulus matrix integrity within intact follicles. Reduced cumulus cell adherence to the cumulus-oocyte-complex (COC) matrix was also observed in isolated COCs and notably occurred late during the maturation window without affecting oocyte maturation. Visualization of PCSK transcript and protein expression, as well as selective inhibition of specific PCSKs, determined that the observed phenotype in COCs is likely attributed to PCSK5A inhibition. We conducted bulk RNA-sequencing and proteomics of PCI-treated COCs which revealed that PCSK inhibition caused dysregulation of extracellular matrix organization, cell migration/adhesion, and TGF-β signaling pathways. Subsequent validation showed that this inhibition translated to disrupted matrix organization and altered migratory and adhesive behaviors in cumulus cells. The TGF-β ligand GDF9 has a predicted PCSK cleavage site, and supplementation with GDF9 rescued matrix integrity suggesting its role as a downstream substrate of PCSKs to regulate matrix organization. Altogether, this study identified PCSK5A and GDF9 as key regulators of COC matrix integrity and cumulus cell migration during late ovulation. These findings highlight novel factors required for follicle rupture which can be leveraged for the development of fertility therapeutics and contraceptives.
    DOI:  https://doi.org/10.64898/2026.07.22.738304
  2. Proc Natl Acad Sci U S A. 2026 Aug 04. 123(31): e2605947123
      Oocytes rely on a cohort of proteins whose sustained expression ensures normal meiotic progression and reproductive competence throughout an animal's reproductive life. Age-related declines in these proteins are a major cause of reduced oocyte quality and female fertility during reproductive aging. Here, we report that the cohesin regulatory protein PDS5B, a dynamically maintained factor in oocytes, declines with age and plays a noncanonical role in the spindle pole formation independent of its cohesion function during oocyte meiotic maturation. Specifically, we found that PDS5B was expressed throughout the oocyte meiosis and localized at the spindle poles at metaphase stages, while its protein abundance was reduced in aged oocytes, concomitant with decreased messenger ribonucleic acid (mRNA) levels and translational efficiency. Knockdown or heterozygous knockout of PDS5B caused spindle assembly defects, meiotic arrest, and aneuploidy in oocytes, ultimately leading to female subfertility. Mechanistically, immunoprecipitation/mass spectrometry analyses revealed that PDS5B recruited deubiquitinating enzyme USP9X to spindle poles to stabilize nuclear mitotic apparatus and promote proper spindle assembly. Moreover, expression of exogenous PDS5B in aged oocytes partially alleviated meiotic defects associated with advanced maternal age. Altogether, our findings uncover a unique spindle pole-specific function of PDS5B in oocytes and suggest that maintaining PDS5B levels may be a potential strategy to improve the quality of aged oocytes.
    Keywords:  NuMA; PDS5B; USP9X; reproductive aging; spindle pole
    DOI:  https://doi.org/10.1073/pnas.2605947123
  3. Ginekol Pol. 2026 Jul 30.
      Review of current knowledge of the in vitro fertilization (IVF) procedure in patients with diminished ovarian reserve (DOR). Patients with DOR who undergo IVF require special care and an individualized approach due to the poor prognosis. The IVF procedure is multi-stage, and each step should be carefully planned, with treatments tailored to DOR patients. The review article was prepared based on an analysis of the latest research findings and ESHRE recommendations for all stages of in vitro fertilization in patients with DOR. The article discusses the results of 32 articles published over the last 5 years, including 23 articles published in 2024-2026. Clinical stages such as prediction of ovarian reserve, hormonal stimulation of the ovaries, and embryo transfer, and laboratory stages such as the quality and quantity of obtained oocytes and embryos, results of preimplantation genetic testing (PGT-A), and finally implantation potential and live birth rate in DOR patients were discussed.
    Keywords:  diminished ovarian reserve (DOR); in vitro fertilisation (IVF); poor ovarian response (POR)
    DOI:  https://doi.org/10.5603/gpl.112176